Company Profiles

driven by the PitchBook Platform

Atreca

Description

Developer of novel therapeutics designed to focus on applications in cancer treatment. The company's novel therapeutics provide technology for the development of antibody-based therapeutics, vaccines, diagnostics and research reagents in therapy areas including cancer, infectious disease and autoimmune disease and also helps to measure and analyze the structure of clinically successful immune responses to identify antibodies, T cell receptors (TCRs), and targets that are key to successful treatment outcomes in patients, enabling patients to provide an immune response by the identification and generation of functional human antibodies and TCRs without prior knowledge of antigen.

2010

Founded

PRIVATE

Status

Series A

Latest Deal Type

$56M

Latest Deal Amount

$63.1M

Total Amount Raised

3

Investors

Description

Developer of novel therapeutics designed to focus on applications in cancer treatment. The company's novel therapeutics provide technology for the development of antibody-based therapeutics, vaccines, diagnostics and research reagents in therapy areas including cancer, infectious disease and autoimmune disease and also helps to measure and analyze the structure of clinically successful immune responses to identify antibodies, T cell receptors (TCRs), and targets that are key to successful treatment outcomes in patients, enabling patients to provide an immune response by the identification and generation of functional human antibodies and TCRs without prior knowledge of antigen.

Website:

www.atreca.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Drug Delivery

Primary Office

500 Saginaw Drive First Floor Redwood City, CA 94063United States +1 (650) 595-2595
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Atreca's full profile, request a free trial.

    Atreca Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Atreca Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Atreca Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Bill & Melinda Gates FoundationNot-For-Profit Venture CapitalMinority000 0000000 0000
    GlaxoSmithKlineCorporationMinority000 0000000 0000
    Mission Bay CapitalVenture CapitalMinority000 0000000 0000
    Bill & Melinda Gates Foundation Not-For-Profit Venture Capital
    GlaxoSmithKline Corporation
    Mission Bay Capital Venture Capital

    Atreca Executive Team (12)

    NameTitleBoard
    Seat
    Contact
    Info
    Tito Serafini Ph.DCo-Founder, Chief Executive Officer, Chief Scientific Officer, President & Board Member
    Susan BerlandExecutive Vice President & Chief Financial Officer
    Guy Cavet Ph.DCo-Founder & Chief Technology Officer
    Norman Greenberg Ph.DSenior Vice President & Chief Scientific Officer
    Nigel RaySenior Vice President and Chief Business Officer
    Tito Serafini Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer, President & Board Member
    Susan Berland Executive Vice President & Chief Financial Officer
    Guy Cavet Ph.D Co-Founder & Chief Technology Officer
    Norman Greenberg Ph.D Senior Vice President & Chief Scientific Officer
    Nigel Ray Senior Vice President and Chief Business Officer

    Atreca Board Members (8)

    NameRepresentingRoleSinceContact
    Info
    Andrew FarnumBill & Melinda Gates FoundationSenior Program Investment Officer000 0000
    Brian AtwoodSelfChairman000 0000
    David Lacey MDSelfBoard Member000 0000
    Douglas Crawford Ph.DMission Bay CapitalFounder & Managing Director000 0000
    Franklin BergerAtrecaBoard Member000 0000
    Andrew Farnum Senior Program Investment Officer Bill & Melinda Gates Foundation
    Brian Atwood Chairman Self
    David Lacey MD Board Member Self
    Douglas Crawford Ph.D Founder & Managing Director Mission Bay Capital
    Franklin Berger Board Member Atreca
    Request full access to PitchBook